Background/Aims: Hepatocellular carcinoma (HCC) is one of the most common human malignant diseases in the world, and the mechanisms underlying HCC carcinogenesis and progression need further investigation. MicroRNAs play important roles in the development of cancer, and miR-500a is suggested to be deregulated in some types of cancer. However, the underlying molecular mechanisms of miR-500a in HCC remain unknown. Methods: The expression of miR-500a in HCC was analyzed in The Cancer Genome Atlas (TCGA) database and examined in 33 pairs of HCC tissues and matched nontumor tissues. The correlation between miR-500a expression and prognosis of HCC patients was analyzed from the survival data in TCGA. The mechanism of miR-500a upregulation in HCC was detected using chromatin immunoprecipitation-quantitative real-time PCR. The roles of miR-500a in HCC development were examined using a cell counting kit-8 assay in vitro and growth of transplanted tumors in nude mice in vivo. Apoptosis of HCC was detected using Annexin V/propidium iodide staining. The expression of BH3-interacting death agonist (BID) protein was examined using western blot analysis. Results: miR-500a expression was upregulated in HCC tissues, and high miR500a expression was significantly correlated with the poor prognosis of HCC patients. Histone modifications in the promoter region of miR-500a may be responsible for its increased expression. Inhibition of miR-500a in HCC cell lines significantly promoted apoptosis, as well as inhibiting the proliferation of HCC cells and growth of transplanted tumors in nude mice. miR-500a directly targeted the 3′ untranslated region of BID mRNA, and inhibition of miR500a-promoted apoptosis was almost completely abolished by the administration of ABT-199 via the BID-mitochondria pathway. Conclusion: Our results suggest that histone modifications
MicroRNA-500a Promotes the

Introduction
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths, especially in China [1] . However, because of its complicated process with multiple factors and steps, its etiological factors and pathogenesis are still not entirely clear. Therefore, the clinical treatments for liver cancer are limited, and surgery remains the most common therapeutic approach. However, low curative rates, high recurrence rates, and heterogeneity reduce the efficacy of surgery [2, 3] . Thus, for individualized targeted therapies of HCC, further investigation of HCC pathogenesis and the discovery of potential therapeutic targets are urgently needed.
Deregulated epigenetic modifications, including DNA and histone modifications, have been suggested to be important for the development of cancer, especially for HCC carcinogenesis and progression [4] . Epigenetic modifications can transcriptionally regulate the expression of mRNA, microRNA (miRNA), long non-coding RNA, and other genes in chromosomes or gene clusters by adjusting chromatin structure without changing the DNA sequence. In recent years, an increasing number of studies have revealed the increased expression of long non-coding RNAs [5, 6] and miRNAs [7] [8] [9] in HCC. However, due to the complexity of epigenetic modifications and limitations of research methods, we have a limited understanding of the mechanisms by which epigenetic modifications are involved in HCC processes through the regulation of gene transcription. Therefore, the roles of deregulated epigenetic modifications in the development of HCC require further investigation. miRNAs are a class of endogenous, non-coding RNAs of approximately 20-22 nucleotides in length that are widespread in eukaryotes. These molecules account for approximately 1% of the entire human genome and are expressed widely in various tissues [10] . miRNAs can directly target the 3′-untranslated regions (3'-UTRs) of target genes and then inhibit the translation or induce the degradation of these mRNAs. Functional studies have confirmed that miRNAs play vital roles in various important biological processes, including proliferation, differentiation, apoptosis, and migration; thus, they have important roles in the properties of cancer biology and may serve as potential therapeutic targets [7, 11, 12] . For HCC, a set of deregulated miRNAs has been shown to participate in its carcinogenesis and progression, and the miRNome study in HCC tissues suggested some important deregulated miRNAs in HCC cancer biology, such as miR-361 [8] , miR-122 [13] , and miR-199 [14] . However, as multiple miRNAs are deregulated in cancer cells and a single miRNA can target multiple mRNAs, identifying the deregulated miRNAs in HCC and uncovering their roles in HCC development is an ongoing process.
In our previous study, we found that the expression of miRNA miR-500a was significantly increased in HCC as compared to normal liver according to heat map analysis of RNA sequencing in The Cancer Genome Atlas (TCGA) database [14] . Also, previous studies have shown that miR-500a is of great interest in cancer therapies due to its association with various types of cancer, including gastric cancer [15] and prostate cancer [16] . Here, we found that high miR-500a expression in HCC tissues was significantly correlated with the poor prognosis of patients; thus, we focused on the roles and corresponding mechanisms of miR-500a in the carcinogenesis and progression of HCC.
Materials and Methods
Cell culture and transfection
Human HCC cell lines (SMMC-7721 and HepG2), a human hepatocyte cell line (QSG-7701), and the HEK293 cell line were purchased from the American Type Culture Collection (Manassas, VA, USA). SMMC-7721, HepG2, QSG-7701, and HEK293 cells were cultured in RPMI-1640 (Invitrogen, Carlsbad, CA, USA) medium containing 10% fetal bovine serum (BioWest, Nuaillé, France) under an atmosphere of 5% CO 2 at 37°C. For transfection experiments, 2.5 × 10 5 SMMC-7721 or HepG2 cells were seeded in a 6-well plate and cultured overnight, and then transfected with 50 nM miR-500a negative controls, inhibitor, or mimics (RiboBio, Guangzhou, China) using Lipofectamine 2000 (Invitrogen) for transfection according to the manufacturer's instructions.
Patient samples
A total of 33 pairs of HCC tissues and matched adjacent liver tissues were collected from surgically resected samples at the Department of Liver Surgery and Organ Transplantation, Changzheng Hospital, Second Military Medical University (Shanghai, China). No patients had a history of chemotherapy or radiotherapy before surgery. The clinical stages of HCC tumors were determined according to the tumornode-metastasis classification system of the International Union Against Cancer (7th edition). The research protocol was approved by the Ethics Committee of the Second Military Medical University, and informed written consent was obtained from each patient according to the Declaration of Helsinki and its amendments.
Quantitative real-time polymerase chain reaction
According to our previous method [13] , TRIzol (Invitrogen) was used to extract total RNA from HCC cell lines. A PrimeScript RT Reagent Kit (Takara, Shiga, Japan) was used for reverse transcription of miR500a using the stem-loop reverse transcription primer. According to the manufacturer's instructions, SYBR Premix Ex Taq (Takara) was used to perform quantitative analysis with a StepOne Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The following primers were used: miR-500a forward reverse transcription primer: 5′-CTC AAC TGG TGT CGT GGA GTC GGC AAT TCA GTT GAG TCT CAC CC-3′; quantitative PCR forward primer: 5′-ACA CTC CAG CTG GGT AAT CCT TGC TAC CTG G-3′ and reverse primer: 5′-TGG TGT CGT GGA GTC G-3′. U6 was used as an internal control. The relative expression of miR-500a was analyzed by the 2 -∆∆CT method.
Chromatin immunoprecipitation assay and real-time PCR
The cells were cross-linked and processed according to the Millipore Chromatin Immunoprecipitation (ChIP) Assay Kit (Millipore, Billerica, MA, USA) protocol. Antibodies (5 mg) to H3K4me3, H3K9me3, H3K27me3, acH3, or control IgG (all from Millipore) were used to immunoprecipitate the respective histone residues. Sonicated preimmunoprecipitated DNA (10 µL) from each sample was used as an input control. ChIP DNA was analyzed by real-time PCR as described previously [13] using the following primers. Primer 1: forward: 5′-CGA TGG AGC AAT TCG ATC GGC-3′; reverse: 5′-GGA TCG AGG CAT CGG ACG GT-3′; and Primer 2: forward: 5′-CGA TGG AGC AAT TCG ATG ATC G-3′; reverse: 5′-GCA TCC GAA GGG TAC GCA TTG C-3′.
Cell proliferation assay
Cell survival experiments were performed using the Cell Counting Kit-8 (CCK-8; Dojindo, Shanghai, China) following the manufacturer's instructions. 2×10 3 SMMC-7721 or HepG2 cells were seeded in 96-well plates (100 µL/well), then transfected with miR-500a inhibitor or miR-NC for 24 h. Then, the medium was replaced with 200µL fresh medium containing 10% FBS and began CCK8 assay, each time-point had sister group wells for detection. The cells were examined using CCK-8 (10 µL/well) analysis for 2 h at 37°C and then evaluated with an automatic microplate spectrophotometer at 490 nm to calculate the optical density value.
Apoptosis analysis
The cells were plated in 12-well plates at a density of 1.0 × 10 5 cells/well and cultured overnight. At 24 h after transfection with miR-500a inhibitor, collected both floating and adherent cells. 0.25% trypsin-EDTA was used to detach adherent cells. According to the manufacturer's instructions, the cells were stained with FITC-Annexin V and propidium iodide (BD Biosciences, Franklin Lakes, NJ, USA). Flow cytometry (Accuri C6; BD Biosciences) was performed to determine the ratio of apoptosis, and the data were analyzed using the Accuri™ C6 built-in software. Annexin V-positive cells were regarded as apoptotic cells.
Dual luciferase reporter assay
A dual-luciferase reporter assay (Promega, Madison, WI, USA) was conducted according to the manufacturer's instructions. BH3-interacting death agonist (BID) 3′-UTR fragments were obtained by PCR and cloned into the pGL3 vector. HEK293 cells were plated on 96-well plates at a density of 5×10 3 cells/ well and incubated overnight, then transfected with 80 ng luciferase reporter plasmid, 40 ng RL-TK-Renillaluciferase plasmid, and 20 nM miR-500a mimics for 48 h. Firefly luciferase activity was normalized using Renilla luciferase activity to balance transfection efficacy.
Western blot analysis
A Mitochondria/Cytosol Isolation Kit (BioVision, Inc., Milpitas, CA, USA) was used to separate cytoplasmic and mitochondrial proteins according to the manufacturer's instructions. According to our previous method [14] , the obtained proteins were quantified by the BCA (Thermo Fisher Scientific, Waltham, MA, USA) method. After denaturation, equal amounts of proteins (500 ng/µL, 10 µL) from different samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes (Millipore). The blots were probed with the following antibodies: BID (ab32060; Abcam, Cambridge, UK), truncated BID (tBID) (ab108293; Abcam); cytochrome C (11940; Cell Signaling Technology, Danvers, MA, USA); cleaved caspase-3 (9654; Cell Signaling Technology); cleaved caspase-9 (7237; Cell Signaling Technology); and GAPDH (5174; Cell Signaling Technology). After washing, the membranes were incubated with a secondary antibody. Chemiluminescence (4200; Tanon Science & Technology, Shanghai, China) was used to detect the signals, and ImageJ 1.49v software (National Institutes of Health, Bethesda, MD, USA) was used for quantitative analysis of the signals.
Xenograft HCC model
Animal experiments were approved by the Scientific Investigation Board of the Second Military Medical University and performed in accordance with the guidelines of the National Institutes of Health Guidance for the Care and Use of Laboratory Animals. SMMC-7721 cells (2.0 × 10 6 cells) were inoculated hypodermically into 6-week-old male BALB/c nude mice (Sippr-BK Laboratory Animal Co., Ltd., Shanghai, China). Two weeks later, nude mice with tumor volumes of 0.5 cm 3 were injected with 20 nM antagomiR500a-3p intratumorally every 3 days (RiboBio). Two weeks later, the mice were sacrificed and the tumors were removed to be measured and photographed.
Statistical analysis
GraphPad Prism software 6.0 (GraphPad Software, La Jolla, CA, USA) was used for statistical analysis and figure preparation. Kaplan-Meier survival analysis was used to analyze the survival data of HCC patients with a log-rank test for significance. Experimental data are expressed as the mean ± standard deviation (SD) or as percentages. Student's t-test was performed to compare two groups of data. Differences were deemed statistically significant when *p < 0.05, **p < 0.01, and ***p < 0.001.
Results
miR-500a expression is significantly increased in HCC
To investigate the expression of miR-500a in HCC, 50 cases of adjacent normal liver tissues and 288 cases of HCC tissues of miRNA chip data in TCGA were analyzed, and we found that miR-500a expression was significantly increased in HCC (Fig. 1A) . Moreover, we collected 33 paired HCC tissues and matched adjacent normal liver tissues, and found that 27 of the 33 HCC samples showed significantly increased miR-500a expression using quantitative real-time PCR analysis (Fig. 1B) . miR-500a expression was also significantly increased in the HCC cell lines SMMC-7721 and HepG2, but not in the liver cell line QSG-7701 (Fig. 1C) . Additionally, based on the clinical data of 288 HCC samples in TCGA, high miR-500a expression in HCC tissues was significantly correlated with the poor prognosis of patients (Fig. 1D) . Thus, we concluded that miR-500a expression is increased in HCC, and high miR500a expression predicts poor prognosis.
Increased miR-500a in HCC is mediated by deregulated histone modifications
We next examined the underlying mechanisms for the increased expression of miR500a in HCC. Deregulated histone modifications have been suggested to be important Cellular Physiology and Biochemistry
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for the gene expression profile in cancer. For example, acetylation and tri-methylation of histone H3 at Lys4 (H3K4me3) are linked to transcriptional activation, while tri-methylation of H3 at K9 (H3K9me3) or K27 (H3K27me3) is linked to transcriptional repression [13] .
We performed ChIP-quantitative PCR analysis to detect the methylation and acetylation of histone H3 in the miR-500a promoter region. The results showed that the levels of H3K4me3 in miR-500a promoter region were significantly increased in HCC SMMC-7721 and HepG2 cells as compared with the liver cell line QSG-7701, and H3K9me3 and H3K27me3 levels were significantly decreased. Moreover, the acetylation level of H3 was also significantly increased in HCC cells ( Fig. 2A-D) . These data suggested that the deregulated histone modifications in the miR500a promoter region may be responsible for its increased expression in HCC.
Inhibition of miR-500a promotes apoptosis of HCC cells
As high miR-500a expression in HCC predicts poor prognosis, the potential roles of miR-500a in HCC progression were then investigated.
Transfection of miR-500a inhibitor significantly decreased miR500a expression in the HCC cell lines SMMC-7721 and HepG2 (Fig. 3A) , and the proliferation of these cells was significantly suppressed by inhibition of miR-500a (Fig. 2B-C) . These data indicate that miR-500a promotes HCC progression in vitro. Furthermore, we used HCC SMMC-7721 cells to build a subcutaneous xenograft model in nude mice, and then injected antagomiR-500a-3p intratumorally to inhibit the expression if miR-500a in 2D) . Thus, high miR-500a expression in HCC promotes tumor growth both in vivo and in vitro. In addition, we examined the roles of miR-500a in regulating HCC apoptosis, and found that inhibition of miR-500a promoted the apoptosis of HCC cells, as determined using flow cytometry (Fig. 2E) . Together, these data suggest that high miR-500a expression in HCC may inhibit HCC apoptosis to promote progression.
miR-500a directly targets BID
To investigate the underlying mechanism for the apoptosis-inhibiting role of miR-500a in HCC cells, we used the TargetScan prediction method to identify potential targets of miR-500a. Among the mRNAs predicted to be targeted by miR-500a, the Bcl-2 family member BID was the most closely related to apoptosis and contributes to the induction of apoptosis (Fig. 3A) . Therefore, we constructed a dual luciferase reporter system containing the 3′-UTR region of BID and found that luciferase activity was significantly reduced by co-transfection with miR-500a mimics, whereas a luciferase reporter containing a mutated potential target site in the 3′-UTR of BID failed to be targeted by miR-500a (Fig. 4B) . Moreover, BID protein expression was also enhanced by inhibition of miR-500a in HCC HepG2 and SMMC-7721 cells (Fig. 4C) . These results indicate that BID mRNA is targeted directly by miR-500a, which may contribute to its apoptosis-inhibiting role in HCC.
It is well known that BID can induce cell apoptosis via the tBID-mitochondrial pathway [17] . Therefore, we examined the activation of the BID downstream pathway in HCC HepG2 and SMMC-7721 cells. Inhibition of miR-500a significantly increased the levels of tBID and cytochrome C in the mitochondria and enhanced caspase-3 and caspase-9 activation (Fig. 4D). These results suggest that miR-500a inhibits HCC apoptosis by targeting the tBIDmitochondrial apoptosis pathway.
BID is responsible for the miR-500a-mediated inhibition of apoptosis
To further clarify the role of BID in the miR-500a-mediated inhibition of apoptosis, we treated HCC SMMC-7721 and HepG2 cells with the Bcl-2 inhibitor ABT-199. miR-500a expression was not influenced by ABT-199 administration in SMMC-7721 and HepG2 cells (Fig. 5A) , and we found that the miR-500a-mediated inhibition of apoptosis was almost abolished by ABT-199 administration (Fig. 5B) . Thus, these data demonstrate that miR-500a exerts its apoptosis-inhibiting function mainly through targeting the apoptosis inducer BID.
Discussion
Previous studies have shown that a set of miRNAs was deregulated in HCC, and some of them play important roles in the carcinogenesis and progression of HCC [18] [19] [20] [21] . In addition, some of these deregulated miRNAs can be used as diagnostic or prognostic markers. For miR-500a, it was suggested that it was increased in the sera of HCC patients and returned to normal after surgical resection; thus, it may be a diagnostic marker for human HCC [22] . It was also suggested that miR-500a may be important for the maintenance of cancer stem cell properties [23] . In the present study, we found that miR-500a was significantly increased in HCC tissues, and high miR-500a expression predicted poor prognosis, thus suggesting that miR-500a may be a potential prognostic and therapeutic target of HCC.
The biosynthesis and degradation of miRNAs are regulated elaborately, and their regulation includes epigenetic, transcription factor, and post-transcriptional processing mechanisms. Among them, the epigenetic regulation of miRNA expression is of great importance, especially histone modifications. Histone modifications include methylation, acetylation, and other modification processes. The trimethylation of histone is stable, and trimethylation at different loci can generate different effects. Generally, the methylation of H3K4, H3K36, and H3K79 is related to transcriptional activation, while the methylation of H3K9, H3K27, and H4K20 exerts an inhibitory effect on transcription. Meanwhile, histone acetylation can enhance the transcriptional level of a gene temporarily [24] . Similarly, our data show that the upregulation of miR-500a in HCC cells may be mediated by the upregulation of histone H3K4 methylation, downregulation of H3K9 and H3K27 methylation, and upregulation of H3 acetylation.
BID protein, which is related to the death receptor pathway and mitochondrial pathwayinduced apoptosis, is very effective at promoting apoptosis [25] . BID is mainly located in the cytoplasm and does not show pro-apoptotic activity. However, when caspase-8 is activated, BID is recognized and cleaved to the activated form of the protein, termed as tBID, and tBID is transported from the cytoplasm to the outer mitochondrial membrane to combine with Bcl-2 protein and inhibit its anti-apoptotic effect [17, 26] or increase mitochondrial permeability to induce the release of cytochrome C, thus activating downstream caspase-3 and caspase-9 to promote apoptosis [27] . Recently, miR-20a was found to target the BID gene directly and induce apoptosis in the TRAIL-resistant rectal cancer cell line SW480 through the tBIDmitochondrial pathway. tBID enhances apoptosis via the mitochondrial pathway [28] only in specific types of cell, namely, CD95 type I cells [29] . Some studies have shown that apoptosis in HepG2 and SMMC-7721 [30, 31] cells was regulated by the tBID-mediated-mitochondrial pathway, which is in accordance with the findings of the present study. The discovery that miR-500a inhibits cell apoptosis by suppressing the tBID-mitochondrial apoptosis pathway adds a new aspect to the regulation of apoptosis by BID.
An miRNA often has a set of targets and then regulates multiple signaling pathways involved in cancer development [32] . For miR-122, it can inhibit proliferation and induce apoptosis by directly targeting cyclin G1 [33] or by directly targeting the Wnt/β-catenin pathway [34] , and can even affect the metabolism of HCC by directly targeting pyruvate
